The Weight-Loss Drug Wegovy Now Comes in a Pill

People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take the medication. On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Wegovy pill from Novo Nordisk. The pill will contain 25 mg of semaglutide—the same compound in the […]

Seven Biopharma Trends to Watch in 2026

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last spring. Blair cited the SPDR S&P Biotech exchange-traded fund (NYSE Arca: XBI), which bounced back from $66.66 a share on April […]

Novo Nordisk Gets US Approval for Wegovy Obesity Pill

Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help […]

Novo Nordisk’s Wegovy Pill Becomes First FDA-Approved Oral GLP-1 Drug for Weight Loss

Beyond weight reduction and long-term maintenance of weight loss, the FDA decision for oral Wegovy covers use of the once-daily pill for reducing the risk of major cardiovascular events. Novo Nordisk expects the Wegovy tablet will launch in early January. The post Novo Nordisk’s Wegovy Pill Becomes First FDA-Approved Oral GLP-1 Drug for Weight Loss […]

Novo’s Wegovy pill to test demand from consumers with cash – Reuters

Novo’s Wegovy pill to test demand from consumers with cash  Reuters Novo Nordisk stock surges on hopes Wegovy pill approval will deliver some ‘redemption’ for investors  CNBC The FDA just approved the first GLP-1 weight-loss pill. Here’s what to know.  The Washington Post With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins  CNN […]